Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 33.17%.

  • Ekso Bionics Holdings' EBIT Margin rose 307500.0% to 33.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 74.9%, marking a year-over-year decrease of 88500.0%. This contributed to the annual value of 58.35% for FY2024, which is 243200.0% up from last year.
  • Latest data reveals that Ekso Bionics Holdings reported EBIT Margin of 33.17% as of Q3 2025, which was up 307500.0% from 193.24% recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' EBIT Margin ranged from a high of 33.17% in Q3 2025 and a low of 193.24% during Q2 2025
  • Moreover, its 5-year median value for EBIT Margin was 97.0% (2022), whereas its average is 101.02%.
  • Its EBIT Margin has fluctuated over the past 5 years, first soared by 1613400bps in 2021, then crashed by -1460700bps in 2025.
  • Over the past 5 years, Ekso Bionics Holdings' EBIT Margin (Quarter) stood at 111.68% in 2021, then decreased by -12bps to 124.92% in 2022, then surged by 43bps to 71.16% in 2023, then soared by 38bps to 43.81% in 2024, then increased by 24bps to 33.17% in 2025.
  • Its last three reported values are 33.17% in Q3 2025, 193.24% for Q2 2025, and 101.93% during Q1 2025.